Literature DB >> 21159975

Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity.

Thomas P Giordano1, Thomas F Tropea, Shirish S Satpute, Martina J Sinnegger-Brauns, Joerg Striessnig, Barry E Kosofsky, Anjali M Rajadhyaksha.   

Abstract

L-type Ca(2+) channel (LTCC)-activated signaling cascades contribute significantly to psychostimulant-induced locomotor sensitization; however, the precise contribution of the two brain-specific subunits Ca(v)1.2 and Ca(v)1.3 remains mostly unknown. In this study, by using amphetamine and cocaine locomotor sensitization in mutant mice expressing dihydropyridine (DHP)-insensitive Ca(v)1.2 LTCCs (Ca(v)1.2DHP(-/-)), we find that, as opposed to a previously identified role of the Ca(v)1.3 subunit of LTCCs in development of sensitization, the Ca(v)1.2 subunit mediates expression of amphetamine and cocaine sensitization when examined after a 14 d drug-free period. Molecular studies to further elucidate the role of Ca(v)1.2 versus Ca(v)1.3 LTCCs in activating signaling pathways in the nucleus accumbens (NAc) of drug-naive versus drug-preexposed mice examined 14 d later revealed that an acute amphetamine and cocaine challenge in drug-naive mice increases Ser133 cAMP response element-binding protein (CREB) phosphorylation in the NAc via Ca(v)1.3 channels and via a dopamine D(1)-dependent mechanism, independent of the extracellular signal-regulated kinase (ERK) pathway, an important mediator of psychostimulant-induced plasticity. In contrast, in amphetamine- and cocaine-preexposed mice, an amphetamine or cocaine challenge no longer activates CREB unless Ca(v)1.2 LTCCs are blocked. This Ca(v)1.2-dependent blunting of CREB activation that underlies expression of locomotor sensitization occurs only after extended drug-free periods and involves recruitment of D(1) receptors and the ERK pathway. Thus, our results demonstrate that specific LTCC subunits are required for the development (Ca(v)1.3) versus expression (Ca(v)1.2) of psychostimulant sensitization and that subunit-specific signaling pathways recruited by psychostimulants underlies long-term drug-induced behavioral responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159975      PMCID: PMC3077109          DOI: 10.1523/JNEUROSCI.2255-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  Repeated cocaine modifies the mechanism by which amphetamine releases dopamine.

Authors:  R C Pierce; P W Kalivas
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

2.  Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons.

Authors:  D J Surmeier; J Bargas; H C Hemmings; A C Nairn; P Greengard
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

3.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

Review 4.  The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants.

Authors:  M E Wolf
Journal:  Prog Neurobiol       Date:  1998-04       Impact factor: 11.685

Review 5.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.

Authors:  P W Kalivas; J Stewart
Journal:  Brain Res Brain Res Rev       Date:  1991 Sep-Dec

Review 6.  The neural basis of drug craving: an incentive-sensitization theory of addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Brain Res Brain Res Rev       Date:  1993 Sep-Dec

7.  Calcium channel blockers and behavioral sensitization.

Authors:  R Karler; S A Turkanis; L M Partlow; L D Calder
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

8.  Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine.

Authors:  R C Pierce; E A Quick; D C Reeder; Z R Morgan; P W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  1998-09       Impact factor: 4.030

9.  Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum.

Authors:  F C Liu; A M Graybiel
Journal:  Neuron       Date:  1996-12       Impact factor: 17.173

10.  Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits.

Authors:  J W Hell; R E Westenbroek; C Warner; M K Ahlijanian; W Prystay; M M Gilbert; T P Snutch; W A Catterall
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

View more
  28 in total

1.  Cav1.2 L-type Ca²⁺ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels.

Authors:  Kathryn Schierberl; Jin Hao; Thomas F Tropea; Stephen Ra; Thomas P Giordano; Qinghao Xu; Sandra M Garraway; Franz Hofmann; Sven Moosmang; Joerg Striessnig; Charles E Inturrisi; Anjali M Rajadhyaksha
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

2.  The role of L-type calcium channels in the development and expression of behavioral sensitization to ethanol.

Authors:  Julie Broadbent
Journal:  Neurosci Lett       Date:  2013-08-28       Impact factor: 3.046

3.  Extinction of Contextual Cocaine Memories Requires Cav1.2 within D1R-Expressing Cells and Recruits Hippocampal Cav1.2-Dependent Signaling Mechanisms.

Authors:  Caitlin E Burgdorf; Kathryn C Schierberl; Anni S Lee; Delaney K Fischer; Tracey A Van Kempen; Vladimir Mudragel; Richard L Huganir; Teresa A Milner; Michael J Glass; Anjali M Rajadhyaksha
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

Review 4.  Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission.

Authors:  R Christopher Pierce; Marina E Wolf
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

5.  Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms.

Authors:  Michael J McCarthy; Melissa J Le Roux; Heather Wei; Stephen Beesley; John R Kelsoe; David K Welsh
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 6.  CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease.

Authors:  Shambhu Bhat; David T Dao; Chantelle E Terrillion; Michal Arad; Robert J Smith; Nikolai M Soldatov; Todd D Gould
Journal:  Prog Neurobiol       Date:  2012-06-15       Impact factor: 11.685

Review 7.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

8.  Mechanism of Manganese Dysregulation of Dopamine Neuronal Activity.

Authors:  Min Lin; Luis M Colon-Perez; Danielle O Sambo; Douglas R Miller; Joseph J Lebowitz; Felix Jimenez-Rondan; Robert J Cousins; Nicole Horenstein; Tolunay Beker Aydemir; Marcelo Febo; Habibeh Khoshbouei
Journal:  J Neurosci       Date:  2020-06-23       Impact factor: 6.167

9.  Differential Roles for L-Type Calcium Channel Subtypes in Alcohol Dependence.

Authors:  Stefanie Uhrig; David Vandael; Andrea Marcantoni; Nina Dedic; Ainhoa Bilbao; Miriam A Vogt; Natalie Hirth; Laura Broccoli; Rick E Bernardi; Kai Schönig; Peter Gass; Dusan Bartsch; Rainer Spanagel; Jan M Deussing; Wolfgang H Sommer; Emilio Carbone; Anita C Hansson
Journal:  Neuropsychopharmacology       Date:  2016-12-01       Impact factor: 7.853

10.  Cocaine-induced locomotor sensitization in rats correlates with nucleus accumbens activity on manganese-enhanced MRI.

Authors:  Shane A Perrine; Farhad Ghoddoussi; Kirtan Desai; Robert J Kohler; Ajay T Eapen; Michael J Lisieski; Mariana Angoa-Perez; Donald M Kuhn; Kelly E Bosse; Alana C Conti; David Bissig; Bruce A Berkowitz
Journal:  NMR Biomed       Date:  2015-09-28       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.